August Newsletter 2018
The Colorado Center for Gynecologic Oncology is excited to share our August Newsletter providing patients with new information, upcoming events and inspiring stories.
When the World Shifts – Resilience
It is a strange notion that it can take one moment to shift one’s perspective. We spend a lot of time studying what is wrong in the world around us. We ask why me? Why is this happening? Perhaps another potential question to ask is…why not me?
Details
HPV Vaccines Protect Against Precancerous Cervical Lesions
Vaccination against the human papillomavirus (HPV) is highly protective against precancerous cervical lesions in adolescents and young women compared with placebo, especially those who are negative for HPV at the time of vaccination, a systematic Cochrane review concludes.
Details
Endometriosis Raises Risk of Ovarian Cancer but Not Other Gynecological Cancers, Study Suggests
Women with endometriosis are at an increased risk of developing ovarian cancer, but not cervical cancer or other cancers affecting the female reproductive organs, a nationwide Finnish study suggests.
Details
FDA Approves First Biosimilar to Neulasta to Help Reduce the Risk of Infection During Cancer Treatment
The U.S. Food and Drug Administration today approved Fulphila (pegfilgrastim-jmdb) as the first biosimilar to Neulasta (pegfilgrastim) to decrease the chance of infection as suggested by febrile neutropenia (fever, often with other signs of infection, associated with an abnormally low number of infection-fighting white blood cells), in patients with non-myeloid (non-bone marrow) cancer who are receiving myelosuppressive chemotherapy that has a clinically significant incidence of febrile neutropenia.
Details